Document is current
Any future updates will be listed below
-
Authors
Pan, Chaoyun
Kang, JiHoon
Hwang, Jung Seok
Li, Jie
Boese, Austin C.
Wang, Xu
Yang, Likun
Boggon, Titus J. https://orcid.org/0000-0003-2862-1637
Chen, Georgia Z.
Saba, Nabil F.
Shin, Dong M.
Magliocca, Kelly R.
Jin, Lingtao
Kang, Sumin https://orcid.org/0000-0001-5111-0232
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (F31 CA246889, R37 CA249305)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA207768, CA175316)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
- License Information
-
More Information
Article History
Received: 15 October 2020
Accepted: 6 July 2021
First Online: 16 August 2021
Competing interests
: S.K. and L.J. are inventors of “Use of MAST1 inhibitor in treatment of platinum-based chemotherapy” technology. The other authors declare no competing interests.
